NCT01492153 NovoLet® Surveillance Study on Using Human Insulin System in Indonesia Status COMPLETED Phase N/A
NCT01490658 Single Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet in Fed Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01490099 Comparison of Insulin Detemir Produced by the Current Process and the NN729 Process in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01489644 Single Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01489111 Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A. Status COMPLETED Phase PHASE3
NCT01487811 Comparison of Two Biphasic Insulin Aspart 30 Formulations (Current and New Formulation) in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01487798 Frequency of Episodes of Hypoglycaemia During Treatment With Biphasic Insulin Aspart 30 in Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT01487421 An Observational Study of Insulin Aspart and, if Necessary, Insulin Levemir (FlexPen®) in the Evening or at Bedtime Status COMPLETED Phase N/A
NCT01487369 Special Survey of Production of Insulin Aspart Specific Antibody Status COMPLETED Phase N/A
NCT01487304 Impact of Professional Societies' Recommendations on Practical Use of Hormone Replacement Therapy Status COMPLETED Phase N/A
NCT01486979 Pharmacokinetic Assessment of the Absorption of Estradiol in Postmenopausal Women With Atrophic Vaginitis Status COMPLETED Phase PHASE1
NCT01486966 Comparing Efficacy and Safety of Insulin Detemir Plus Insulin Aspart and NPH Insulin Plus Human Soluble Insulin With or Without Metformin in Chinese Patients With Type 2 Diabetes Status TERMINATED Phase PHASE4
NCT01486940 Comparison of Insulin Detemir Plus Insulin Aspart With Insulin NPH Plus Human Soluble Insulin in Subjects With Type 1 Diabetes Status COMPLETED Phase PHASE3
NCT01486914 Comparison of Insulin Aspart Produced by Current Process and the NN2000 Process Status COMPLETED Phase PHASE1
NCT01486901 Bioequivalence of Two Insulatard® Formulations in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01486888 Bioequivalence of Two Mixtard® 30 Formulations in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01486875 Observational Study of Safety of NovoMix® 30 Treatment for Type 2 Diabetes Status COMPLETED Phase N/A